A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma

NCT04174196 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Plasmacytoma
Plasmacytoma of Bone
Multiple Myeloma

Interventions

DRUG: CC-486
DRUG: Lenalidomide
RADIATION: Radiation Therapy

Sponsor

Memorial Sloan Kettering Cancer Center